Gibbons Edward F, Huang Gary, Aldea Gabriel, Koomalsingh Kevin, Klein Jared W, Dhanireddy Shireesha, Harrington Robert
From the Cardiology Division, Department of Medicine, Harborview Medical Center, Seattle, WA.
Cardiothoracic Surgery Division, Department of Surgery, University of Washington Medical Center, Seattle, WA.
Crit Pathw Cardiol. 2020 Dec;19(4):187-194. doi: 10.1097/HPC.0000000000000224.
Clinical pathways can be useful when disparate clinical-pathologic groups converge on a common diagnostic and therapeutic trajectory. The progressive increase in the incidence of endocarditis in the US has included higher-risk subjects whose candidacy for aggressive cardiac surgical intervention may be highly resource-intensive, prohibitively high risk, or delayed and possibly deferred by comorbidities. We sought to define the sequence, application, and resolution of multidisciplinary endocarditis team decision-making in 4 distinct clinical groups.
当不同的临床病理群体遵循共同的诊断和治疗路径时，临床路径可能会很有用。在美国，心内膜炎发病率的逐渐上升涉及到风险更高的患者，对他们进行积极的心脏外科干预可能资源消耗极大、风险高得令人望而却步，或者因合并症而延迟甚至可能被推迟。我们试图确定多学科心内膜炎团队在4个不同临床组中的决策顺序、应用和解决方法。
